Hyo Sang Jo

USPTO Granted Patents = 2 (Patent Applications = 4)

EPO Patents = 1 (Patent Applications = 5)

Average Co-Inventor Count = 4.0

ph-index = 1

Company Filing History:

2 out of 4

Yc Corporation

patents

Years Active: 2025

Loading Chart...

2 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12469579 - Semiconductor test apparatus capable of inducing reduction of power consumption (2025-11-11),

2. 12461142 - Semiconductor wafer test system for controlling supply of power to semiconductor wafer test apparatus and method of controlling supply of power to semiconductor wafer test apparatus (2025-11-04),

Title: Hyo Sang Jo - Innovator in Liver Disease Treatment

Introduction

Hyo Sang Jo is an accomplished inventor based in Hwaseong-si, Gyeonggi-do, South Korea. She is currently associated with Hanmi Pharmaceutical Co., Ltd. Despite having no granted patents to her name, her work in the field of therapeutic applications is noteworthy.

Latest Patent Applications

Hyo Sang Jo's recent patent application focuses on the therapeutic use of a glucagon derivative or a conjugate thereof for liver disease. The application details new therapeutic uses of this glucagon derivative, represented by the formula: Y-X2-QGTF-X7-SDYSKY-X14-D-X16-X17-R-X19-X20-X21-FVQWLMNT-X30 (General Formula 1, SEQ ID NO: 46). This innovative approach aims to prevent or treat liver diseases, showcasing her commitment to advancing medical science.

Conclusion

Hyo Sang Jo's contributions to the field of liver disease treatment highlight her potential as an inventor. Her ongoing research and applications may pave the way for significant advancements in therapeutic options for patients.

This text is generated by artificial intelligence and may not be accurate.